ARKK vs XBI
ARK Innovation ETF vs SPDR S&P Biotech ETF
ARKK$79.58
ARK Innovation ETF
Active disruptive-innovation strategy.
Expense: 0.75%Yield: 0.00%
XBI$156.41
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: 0.35%Yield: 0.35%
Quick take
- • XBI has the lower expense ratio at 0.35% vs 0.75% for ARKK.
- • XBI pays a higher dividend yield (0.35%).
Side-by-side metrics
| Metric | ARKK | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $6.12B | $10.92B |
YTD return | 2.68% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.45 | 1.01 |
P/E ratio | 51.36 | — |
Last price | $79.58 | $156.41 |
Inception | — | — |
Issuer | ARK | State Street |
ARKK top holdings
Top holdings · ARKK
| TSLA | Tesla Inc | 10.65% |
| SPCX | Space Exploration Technologies Corp Class A | 6.13% |
| TEM | Tempus AI Inc Class A common stock | 5.61% |
| CRCL | Circle Internet Group Inc Ordinary Shares - Class A | 4.68% |
| CRSP | CRISPR Therapeutics AG | 4.44% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 3.95% |
| TWST | Twist Bioscience Corp | 3.56% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 3.11% |
| NVDA | NVIDIA Corp | 2.93% |
Sector breakdown · ARKK
Consumer Cyclical13.8%
Technology25.3%
Communication Services3.1%
Financial Services14.8%
Industrials12.2%
Healthcare30.8%
XBI top holdings
Top holdings · XBI
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%
About ARKK
ARKK (ARK Innovation ETF) is Active disruptive-innovation strategy. Managed by ARK, the fund carries $6.1B in assets under management, an expense ratio of 0.75%. Its largest holding is Tesla Inc (TSLA), which represents 10.7% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 13.8%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.